Roivant Sciences Other current assets decreased by 18.9% to $105.32M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.9%, from $113.17M to $105.32M. Over 5 years (FY 2020 to FY 2025), Other current assets shows an upward trend with a 14.2% CAGR.
Large, unexpected increases may warrant investigation into potential accounting adjustments or non-recurring items.
This is a catch-all category for current assets that do not fit into standard classifications like cash, receivables, or...
Standard across all industries; usually a minor component of the balance sheet.
current_assets_other_assets_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.17M | $55.56M | $70.33M | $86.12M | $93.27M | $111.85M | $118.80M | $121.77M | $127.07M | $143.40M | $135.92M | $80.61M | $322.99M | $94.23M | $217.46M | $113.17M | $112.60M | $125.81M | $129.91M | $105.32M |
| QoQ Change | — | -4.5% | +26.6% | +22.4% | +8.3% | +19.9% | +6.2% | +2.5% | +4.3% | +12.9% | -5.2% | -40.7% | +300.7% | -70.8% | +130.8% | -48.0% | -0.5% | +11.7% | +3.3% | -18.9% |
| YoY Change | — | — | — | — | +60.4% | +101.3% | +68.9% | +41.4% | +36.2% | +28.2% | +14.4% | -33.8% | +154.2% | -34.3% | +60.0% | +40.4% | -65.1% | +33.5% | -40.3% | -6.9% |